HIBERCELL
HiberCell is a biotechnology company developing treatments to prevent cancer relapse and metastasis. The company was founded in 2019 and is based in New York.
HIBERCELL
Social Links:
Industry:
Biotechnology Health Care Health Diagnostics Medical
Founded:
2019-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.hibercell.com
Total Employee:
11+
Status:
Active
Contact:
212-601-2800
Email Addresses:
[email protected]
Total Funding:
158.15 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon WordPress Content Delivery Network Font Awesome Wordpress Plugins
Similar Organizations
Abdera Therapeutics
Abdera is an oncology company developing targeted alpha therapies (TATs) for patients with relapsed, refractory, and metastatic cancers.
Rakuten Medical
Rakuten Medical is a Bio-technology Company.
Disarm Therapeutics
Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.
ORIG3N
ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases.
Q32 Bio
Q32 Bio is a biotechnology company that develops treatments for patients with severe autoimmune and inflammatory diseases.
Current Employees Featured
Founder
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2021-08-16 | Genuity Science | Genuity Science acquired by HiberCell | 100 M USD |
2020-07-07 | Biothera | Biothera acquired by HiberCell | N/A |
Investors List
ARCH Venture Partners
ARCH Venture Partners investment in Series B - HiberCell
Huizenga Capital Management
Huizenga Capital Management investment in Series B - HiberCell
Magnetic Ventures
Magnetic Ventures investment in Series B - HiberCell
Hercules Capital
Hercules Capital investment in Debt Financing - HiberCell
Monashee Investment Management
Monashee Investment Management investment in Series B - HiberCell
Trinitas Capital
Trinitas Capital investment in Series B - HiberCell
Bristol Myers Squibb
Bristol Myers Squibb investment in Series B - HiberCell
Celgene
Celgene investment in Series A - HiberCell
ARCH Venture Partners
ARCH Venture Partners investment in Series A - HiberCell
Hillhouse Capital Group
Hillhouse Capital Group investment in Series A - HiberCell
Key Employee Changes
Date | New article |
---|---|
2021-09-30 | HiberCell Appoints Jonathan Lanfear as Chief Operating Officer |
Official Site Inspections
http://www.hibercell.com Semrush global rank: 7.28 M Semrush visits lastest month: 544
- Host name: 47.107.198.104.bc.googleusercontent.com
- IP address: 104.198.107.47
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043